Building a strong community of researchers committed to advancing cutting-edge science is critical for getting treatments and cures to patients as quickly as possible. Because of...
“At the current rate of therapeutic development for rare diseases, it will be 2000 years before doctors won’t have to say to patients, ‘There’s nothing more...
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
The Context: The brain activity that enables the rapid back-and-forth of human conversation is likely disrupted in diseases or disorders that interfere with normal communication such...
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
This morning, NYSCF CEO Susan L. Solomon rang the NASDAQ bell to officially open stock trading for the day. “I’m incredibly optimistic about the future of...
This month, NYSCF CEO Susan L. Solomon, JD, spoke at the NYC Builds Bio+ February Quarterly Breakfast (held at the New York Genome Center) about NYSCF’s...
Curing disease takes more than just research– it requires well-planned investment and business strategies that allow science to get done and treatments to move out of...
Last week, thousands of researchers and thought leaders gathered at the annual Phacilitate Leaders World and World Stem Cell Summit in Miami to discuss recent advancements...
The Context: When a major heart artery is blocked, the oxygen-starved areas of the heart are kept healthy by smaller arteries called collateral arteries. Some people...
What they did: A team of researchers from Stanford University led by NYSCF – Robertson Neuroscience Investigator and Assistant Professor of Anesthesiology, Neurosurgery, and Perioperative and...
Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds New York, NY (January 14, 2019) – A team of scientists from...
What They Did: A team of NYSCF scientists led by NYSCF – Ralph Lauren Senior Principal Investigator Dr. Giuseppe Maria de Peppo tested whether mesenchymal progenitor...
Research teams will use stem cell and gene editing technologies to advance cell-based therapies for devastating diseases New York, New York (January 9, 2019) – The...
What They Did: A team led by NYSCF – Robertson Neuroscience Investigator, MIT Professor of Neurotechnology, and Associate Professor of Biological Engineering and Brain and Cognitive...
What They Did: Researchers at the National Institutes of Health (NIH) and Montana State University along with NYSCF Senior Principal Investigator Dr. Valentina Fossati examined cerebrospinal...
It was announced last week that three NYSCF – Robertson Investigators have been named Ben Barres Early Career Investigators by the Chan-Zuckerberg Initiative (CZI). This Early Career...
An epilepsy drug, initially tested using a stem cell model of ALS developed with NYSCF support, has successfully reduced motor neuron excitability (a hallmark of the...
Congratulations to NYSCF – Robertson Stem Cell Investigator and Assistant Professor of Psychiatry and Behavioral Sciences at Stanford University Sergiu Pasca, MD, for receiving the 2018...
“It takes 13 years—after you have sunk 4 billion dollars into a drug—to figure out whether or not it will succeed, and your chance of being...
What They Did: A team of researchers from the University of California, San Francisco led by NYSCF – Robertson Neuroscience Investigator and Professor of Neurological Surgery...
Reports this week that a researcher in China has created genetically modified children using the gene editing technology CRISPR have been met with widespread concern. Dr....
Our skin is made up of three layers. The top layer – the epidermis – contains epithelial cells, which provide a barrier between us and the...
